Column Capital Advisors’s Genmab GMAB Stock Holding History

Column Capital Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$377K	Hold	10,680	–	–	0.06%	100
2023 Q2	$406K	Buy	+10,680	New	+$426K	0.06%	94
2023 Q1	–	Sell	-51	Closed	-$2.16K	–	856
2022 Q4	$2.16K	Hold	51	–	–	﹤0.01%	697
2022 Q3	$2K	Hold	51	–	–	﹤0.01%	626
2022 Q2	$2K	Hold	51	–	–	﹤0.01%	634
2022 Q1	$2K	Hold	51	–	–	﹤0.01%	649
2021 Q4	$2K	Hold	51	–	–	﹤0.01%	657
2021 Q3	$2K	Hold	51	–	–	﹤0.01%	627
2021 Q2	$2K	Hold	51	–	–	﹤0.01%	627
2021 Q1	$2K	Hold	51	–	–	﹤0.01%	614
2020 Q4	$2K	Hold	51	–	–	﹤0.01%	601
2020 Q3	$2K	Sell	51 -306	-86%	-$11.1K	﹤0.01%	593
2020 Q2	$12K	Buy	357 +56	+19%	+$1.53K	﹤0.01%	446
2020 Q1	$6K	Hold	301	–	–	﹤0.01%	461
2019 Q4	$6K	Buy	+301	New	+$6.57K	﹤0.01%	509

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Column Capital Advisors's GMAB Position: Q3 2023 in Review

Column Capital Advisors held its Genmab (GMAB) position steady in Q3 2023 at 10,680 shares worth $377K. The position accounts for 0.06% of the portfolio, ranked #100.

Column Capital Advisors first reported a position in GMAB in Q4 2019 and has held it in 15 quarters since. The position peaked at $406K in Q2 2023. 234 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

Column Capital Advisors held 10,680 shares of Genmab worth $377K as of Q3 2023.
Column Capital Advisors left its Genmab share count unchanged in Q3 2023.
Genmab made up 0.06% of Column Capital Advisors's portfolio in Q3 2023, its #100 holding.
Column Capital Advisors first reported a position in Genmab in Q4 2019 and has held it in 15 quarters since.
Column Capital Advisors's Genmab position peaked at $406K in Q2 2023.
234 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.